Css LLC Regeneron Pharmaceuticals, Inc. Transaction History

Css LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $136,098 - $165,394	-200 Reduced 40.0%	300 $246,000
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $70,589 - $76,639	-100 Reduced 16.67%	500 $360,000
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $119,024 - $139,686	-200 Reduced 25.0%	600 $419,000
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $434,784 - $536,776	800 New	800 $505,000
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $269,761 - $342,900	-564 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $182,491 - $220,500	-335 Reduced 37.26%	564 $316,000
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $443,494 - $578,884	899 New	899 $561,000

1,500

83M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.